Company Intelligence Profile
Ideawise Technologies Private Limited
Operates as "Lifechart" / "Lifechart Ayurveda" — an Ayurveda-based digital wellness and healthtech platform founded in 2021-2022 by Mukul Shah (CEO), Mansi Shah/Sharma (Chief Business Officer) and K Sandeep (CTO).
Last updated 6 August 2026
Ideawise Technologies Private Limited operates as "Lifechart" or "Lifechart Ayurveda," an Ayurveda-based digital wellness and healthtech platform connecting patients with Ayurvedic doctors and selling herbal products. Founded in 2021-2022, the company reported a revenue of approximately Rs 1.28 Cr for FY2025 and has raised over $1 million across two seed funding rounds. In 2024, they launched "Guttify," focusing on India's gut-health market.
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
See what AICA knows about Ideawise Technologies
Deeper analysis, financial signals and peer comparisons.
Company Identity
| Registered name | Ideawise Technologies Private Limited |
|---|---|
| CIN | U72900DL2021PTC382934 |
| PAN | AAGCI2036R — derived by decoding characters 3–12 of GSTIN 07AAGCI2036R1Z7 (standard GSTIN structure) |
| Status | Active |
| Listing | Unlisted (private limited company) |
| Incorporated | 29 June 2021 |
| ROC | RoC-Delhi |
| Sector (NIC) | Sector classified variously as "Computer and related activities", "Internet and Online Healthcare Services", and "Professional, scientific and technical activities" — sources disagree on NIC bucket; operationally the company runs healthtech/D2C wellness brands |
| Registered address | H.No-60-KH No-115, Vijay Vihar, Uttam Nagar, Block N, West Delhi, New Delhi, Delhi - 110059 |
| Authorized capital | Rs 3,00,000 (Rs 3 lakh) — agreed by Tofler and TheCompanyCheck |
| Paid-up capital |
|
Business Overview
- Operates as "Lifechart" / "Lifechart Ayurveda" — an Ayurveda-based digital wellness and healthtech platform founded in 2021-2022 by Mukul Shah (CEO), Mansi Shah/Sharma (Chief Business Officer) and K Sandeep (CTO)
- Lifechart began as an online consultation platform connecting patients to Ayurvedic doctors for chronic conditions (stress, hypertension, sleep disorders, gut issues) and sells herbal syrups/teas D2C via lifechartayurveda.in (Shopify storefront)
- In 2024 it launched "Guttify," India's first diagnosis-led gut-health brand combining at-home diagnostics (pH-based saliva acidity test, planned Rs 99 kits) with Ayurveda-backed products, targeting India's ~$18B gut-wellness market
- DPIIT-recognised startup
- Sources: StartupTalky, YourStory, Entrackr, eHealth Magazine, TheCompanyCheck, Outlook India
Directors
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Mukul Shah ( | 08627198 | - | - |
GST Registrations
| GSTIN | State | PAN | Status |
|---|---|---|---|
| 07AAGCI2036R1Z7 | Delhi | AAGCI2036R — derived by decoding characters 3–12 of GSTIN 07AAGCI2036R1Z7 (standard GSTIN structure); Tofler explicitly lists PAN as "not available," so treat as inferred, not source-confirmed | Active |
Primary GSTIN: 07AAGCI2036R1Z7 (Masters India) — state code 07 = Delhi, consistent with registered office; registered ~7 Sept 2021; status Active; Regular taxpayer; PAN embedded = AAGCI2036R. Only one GSTIN identified (Delhi); no evidence of multi-state registrations found. Single-source confirmation (Masters India only) — partial.
Financials
- Revenue ~Rs 1.28 Cr, reported down ~2% YoY
- EBITDA/PAT figures locked behind paywall on both Tofler and TheCompanyCheck. Tofler additionally reports (as of Mar 2025) Net Profit Margin 7.03%, Return on Equity 7.53%, Debt-to-Equity 0.18 — implying a small positive PAT (~Rs 9 lakh order of magnitude if margin applies to the ~Rs1.28Cr revenue, not independently confirmed). Standalone vs consolidated basis not stated by either source. Filed Annual Returns/Financial Statements up to 31 Mar 2024 per one InstaFinancials-derived summary. Overall: partial, single-source per data point, no full P&L available without paid subscription
Funding
- Two rounds reported: (1) Oct 2024 seed round, ~$500K, led by Prajay Advisors (Unichem Laboratories founders' family office, $250K) with Agility Ventures, Expert Dojo, Sunn91 Ventures, government seed schemes, and angels Nitish Mittersain (Nazara Technologies), Ahana Gautam (Open Secret), Sarath Sura, Marwari Angels (Entrackr, BioSpectrum India)
- (2) May 2025 extended seed round, $360K, co-led by Prajay Advisors and new investor Unichem Labs, same angel base (Entrackr, eHealth Magazine, BW Disrupt, Indian Startup Times)
- Cumulative funding reported as "over $1 million." Multiple consistent trade-press sources (Entrackr, eHealth Magazine, BioSpectrum India, BW Disrupt) — confirmed for round existence/amounts; no valuation disclosed
Charges/Loans
No charges or secured borrowings are registered against this company's assets.
Competitors
Frequently Asked Questions
What does Ideawise Technologies Private Limited do?
What is the CIN of Ideawise Technologies Private Limited?
Where is Ideawise Technologies Private Limited registered?
When was Ideawise Technologies Private Limited incorporated?
Recur Market
Which lenders fit a company like Ideawise Technologies Private Limited?
Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.
Explore on Recur Club
More from Recur Club
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.